DAROLUTAMIDE
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ENDOCRINE THERAPY > HORMONE ANTAGONISTS AND RELATED AGENTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12684NMP | DAROLUTAMIDE darolutamide 300 mg tablet, 112 (PI, CMI) |
1 | 112 | 5 | $3538.57 | $31.60 | $31.60 |
| Available brands | |||||||
| Nubeqa |
DAROLUTAMIDE
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ENDOCRINE THERAPY > HORMONE ANTAGONISTS AND RELATED AGENTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13769QMP | DAROLUTAMIDE darolutamide 300 mg tablet, 112 (PI, CMI) |
1 | 112 | 5 | $3538.57 | $31.60 | $31.60 |
| Available brands | |||||||
| Nubeqa |
- Legend
- MPMedical Practitioner




